- Report
- April 2024
- 330 Pages
Global
From €4749EUR$4,950USD£4,107GBP
- Report
- May 2024
- 190 Pages
Global
From €3237EUR$3,374USD£2,799GBP
€3597EUR$3,749USD£3,111GBP
- Report
- August 2023
- 107 Pages
Global
From €5709EUR$5,950USD£4,937GBP
- Report
- April 2024
- 135 Pages
Global
From €3741EUR$3,899USD£3,235GBP
- Report
- October 2023
- 188 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- December 2023
- 175 Pages
Global
From €2399EUR$2,500USD£2,074GBP
- Report
- February 2024
- 94 Pages
Global
From €3500EUR$3,908USD£3,132GBP
- Report
- May 2020
- 261 Pages
Global
From €5152EUR$5,370USD£4,455GBP
Source Plasma is a type of blood product derived from the plasma of healthy donors. It is used in the manufacture of a variety of therapeutic products, such as clotting factors, albumin, and immunoglobulins. It is also used in the production of vaccines and other biopharmaceuticals. In the blood banking industry, source plasma is collected from donors and then processed and tested for safety before being used in the manufacture of therapeutic products.
Source plasma is a valuable resource for the blood banking industry, as it is used to produce a variety of therapeutic products. It is also used in the production of vaccines and other biopharmaceuticals.
Some companies in the source plasma market include CSL Behring, Grifols, Octapharma, Kedrion, and Biotest. Show Less Read more